Shimadzu Europe
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Free subscriptions
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • FREE newsletter subscription
  • Search
  • Menu Menu
Clinical Laboratory int.
  • Allergies
  • Cardiac
  • Gastrointestinal
  • Hematology
  • Microbiology
  • Microscopy & Imaging
  • Molecular Diagnostics
  • Pathology & Histology
  • Protein Analysis
  • Rapid Tests
  • Therapeutic Drug Monitoring
  • Tumour Markers
  • Urine Analysis

Archive for category: Rapid Tests & POC

Rapid Tests & POC

AdobeStock 1628206991 Omgezet e1762439956239

Point-of-care test for detection of the FKBP12 biomarker at single-molecule level

, 7 November 2025/in Featured Articles, Rapid Tests & POC /by panglobal

FK506 (tacrolimus) binding protein 12 (FKBP12) is involved in fundamental cellular processes as well as immunosuppression, neurodegenerative diseases and cancer. Hence, the ability to quickly and easily determine its levels is desirable. CLI caught up with Dr Pitruzzella, Dr Caminati and Prof. Cennamo to find out more about the point-of-care test that they have developed […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2025/11/AdobeStock_1628206991-Omgezet-e1762439956239.jpg 918 1238 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2025-11-07 14:50:362025-11-06 14:53:00Point-of-care test for detection of the FKBP12 biomarker at single-molecule level
Finland launches pioneering medical device pilot line to accelerate patient-friendly innovations

Finland launches pioneering medical device pilot line to accelerate patient-friendly innovations

, 21 March 2025/in E-News, Rapid Tests & POC, Therapeutic Drug Monitoring /by panglobal

A state-of-the-art pilot line environment established by VTT Technical Research Centre of Finland aims to bridge the critical gap between medical technology research and market-ready products, potentially reducing development timelines for non-invasive diagnostic and monitoring devices.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2025/03/VTT.jpg 480 720 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2025-03-21 10:17:292025-03-21 10:17:29Finland launches pioneering medical device pilot line to accelerate patient-friendly innovations
Scherm­afbeelding 2024 10 25 om 13.01.13

Mapping, monitoring and surveillance of Tropical and Neglected Diseases

, 7 November 2024/in Featured Articles, Rapid Tests & POC /by panglobal

Tropical infectious diseases such as malaria, cholera, yellow fever, and Dengue affect more than 2 billion people worldwide. Also included in this list are the so-called “Neglected Tropical Diseases” or NTD’s, a sub-group of mainly infectious diseases that occur against a background of extreme poverty. The WHO lists 17 priority Neglected Tropical Diseases, among them […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2024/10/Scherm­afbeelding-2024-10-25-om-13.01.13.jpg 824 1102 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2024-11-07 08:45:412024-11-07 08:45:41Mapping, monitoring and surveillance of Tropical and Neglected Diseases
AdobeStock 432389043

Development of rapid and POC tests for viral diagnostics

, 6 November 2024/in Featured Articles, Rapid Tests & POC /by panglobal

It is often said that “necessity is the mother of invention”, something that often seems to happen in war situations. The COVID-19 pandemic, in many ways, felt like a war, and drove fast changes in behaviour, very quickly having us all performing lateral flow tests at home, in a way that could not have been […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2024/11/AdobeStock_432389043.jpeg 1280 1920 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2024-11-06 18:12:502024-11-06 18:53:20Development of rapid and POC tests for viral diagnostics
Autoimmune Encephalitis Mosaic 6

Together at the pulse of neurobiology

, 20 August 2024/in Featured Articles, Autoimmunity & Allergy, Molecular Diagnostics, Rapid Tests & POC /by panglobal

A unique portfolio of neurobiomarker tests The testing landscape for neurological diseases has expanded rapidly in recent years due to the characterisation of many novel biomarkers. With over 15 years of experience in neurological analytics, EUROIMMUN offers an unparalleled portfolio of assays for determination of more than 80 neurobiomarkers in autoimmune diseases, neurological infections and […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2024/08/Autoimmune-Encephalitis-Mosaic-6.jpg 1034 1920 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2024-08-20 08:32:562024-08-22 08:48:19Together at the pulse of neurobiology
revvity liquid handling

Revvity’s Auto-Pure 2400 liquid handler opens new era in automated TB testing

, 19 June 2024/in Product News, Rapid Tests & POC /by panglobal

Revvity has launched their Auto-Pure 2400 liquid handler from Allsheng for use with the T-SPOT.TB test. The Auto-Pure 2400 platform is easy to use and designed to provide efficient workflows in the lab. When the accuracy of the T-SPOT.TB test is combined with the efficiency of the Auto-Pure 2400 system, labs, clinicians and ultimately patients, […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2024/05/revvity_liquid_handling.jpg 650 1914 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2024-06-19 13:23:162024-08-22 08:53:30Revvity’s Auto-Pure 2400 liquid handler opens new era in automated TB testing
ELISA microplate automat kleiner 1

Anti-TBEV ELISAs for CSF and serum

, 24 January 2024/in Product News, Rapid Tests & POC /by panglobal

EUROIMMUN has introduced CE-IVDR-compliant ELISAs for detection of IgG antibodies against tick-borne encephalitis virus (TBEV) in cerebrospinal fluid (CSF) and serum samples. TBEV causes the severe and potentially fatal neurological disease TBE, which is endemic in parts of Europe and Asia and is growing in range and incidence. In TBE cases with CNS involvement, detection […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2024/01/ELISA_microplate_automat-kleiner-1.jpg 452 600 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2024-01-24 12:21:482024-08-22 08:38:29Anti-TBEV ELISAs for CSF and serum
Bio-Rad - Preparing for a Stress-free QC Audit

Latest issue of Clinical laboratory

November 2025

CLi Cover nov 2025
13 November 2025

New Chromsystems Product for Antiepileptic Drugs Testing

11 November 2025

Trusted analytical solutions for reliable results

10 November 2025

Chromsystems | Therapeutic Drug Monitoring by LC-MS/MS

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The leading international magazine for Clinical laboratory Equipment for everyone in the Vitro diagnostics

Sign up today
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Free subscriptions
    • Media kit
    • Submit Press Release
clinlab logo blackbg 1

Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com

PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only

Subscribe now!

Become a reader.

Free subscription